Fasenra (benralizumab)

pCPA File Number: 21066
Negotiation Status:
Concluded with an LOI
Indication(s):
Eosinophilic Asthma
Sponsor/Manufacturer:
AstraZeneca Canada Inc.
CADTH Project Number:
SR0561-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: